By Giridhar Mohan, MPH; Sajal Chattopadhyay PhD.,
Question What are the costs of interventions leveraging social determinants of health to improve breast, cervical, and colorectal cancer screening, and are they cost-effective?
Findings In this systematic review of 30 unique economic evaluations, the median intervention cost per participant was $123.87, the median incremental cost per additional person screened was $250.37, and the median incremental cost per quality-adjusted life-year gained was $3120.00, which was considerably lower than an established conservative threshold for cost-effectiveness.
Meaning This study found that interventions focused on social determinants of health to improve breast, cervical, and colorectal cancer screening appear to be cost-effective for underserved, vulnerable populations in the United States.
Comments (0)